Avid Bioservices to exit public market with GHO and Ampersand buyout
In a transformative shift within the biopharmaceutical manufacturing sector, Avid Bioservices, a premier biologics contract development and manufacturing organization (CDMO), has announced its agreement to ... Read More
Ampersand acquires majority stake in in vitro diagnostics company ALPCO
Ampersand Capital Partners, a middle-market private equity firm, has acquired a majority stake in American Laboratory Products Company (ALPCO), an in vitro diagnostics company, for ... Read More
Thermo Fisher to acquire viral vector CDMO Brammer Bio for $1.7bn
Global life sciences company Thermo Fisher Scientific has agreed to acquire Massachusetts-based Brammer Bio from Ampersand Capital Partners for about $1.7 billion in cash. Brammer ... Read More